Assorted news from last week: The FDA has granted a rare pediatric disease designation (RPDD) to lutetium-177(177Lu)-omburtamab-DTPA for use as a potential therapeutic option in
Assorted news from last week: CAC2 Member Mary Beth Collins, highlights the importance of Childhood Cancer License Plates, how they amplify awareness efforts, the advocacy
Assorted news from the last two weeks: In recognition of Childhood Cancer Awareness Month, NCI Director Ned Sharpless reflected on the progress that’s been made
Assorted news from the last week: This video abstract breaks down financial toxicity issues for families with special health care needs. Researchers have discovered that
Assorted news from the last week: The White House issued a proclamation for Childhood Cancer Awareness Month on September 1. Canadian gold illumination! For every
Assorted news from the last week: Research led by SickKids and the Montreal Children’s Hospital of the McGill University Health Centre found that a novel
Assorted news from the last week: Study finds cancer screening tool may help predict risk of developing new cancer among childhood cancer survivors. NCI has
Assorted news from the last week: The STAR Act was crafted by parents, doctors, and organizations who strive to make a difference for children with
Assorted news from the last week: New York Times op-ed piece by CNN investigative reporter Andrew Kaczynski on the financial toxicity of a childhood cancer
Assorted news from the last two weeks: CAC2 Member blog post: “Diagnostic delays may be improved with targeted programs. The HeadSmart program, a web-based national
